Calendrier des promotions Futura Medical plc
Calendrier avancé
Graphique simple
Grade
Sous-estimation
Nom |
Signification |
Grade |
P/S |
23.16 |
1 |
P/BV |
13.11 |
1 |
P/E |
0 |
0 |
Efficacité
Nom |
Signification |
Grade |
ROA |
-55.09 |
0 |
ROE |
-118.86 |
0 |
ROIC |
0 |
0 |
Dividendes
Nom |
Signification |
Grade |
Rendement en dividendes |
0 |
0 |
DSI |
0 |
0 |
Croissance moyenne du dividende |
0 |
0 |
Devoir
Nom |
Signification |
Grade |
Debt/EBITDA |
0 |
10 |
Debt/Ratio |
0 |
10 |
Debt/Equity |
1.16 |
8 |
Impulsion de croissance
Nom |
Signification |
Grade |
Revenu, % |
10420.31 |
10 |
Ebitda, % |
-38.67 |
0 |
EPS, % |
-51.22 |
0 |
paper.price.prices
|
Prix |
Common.min. |
Common.max. |
Changement |
paper.changes_in_industry |
paper.changes_in_index |
common.calendar.number_days.1 |
0.11 $ |
0 $ |
0 $ |
-9.09 % |
0 % |
0 % |
common.calendar.number_days.7d |
0.11 $ |
0 $ |
0 $ |
-9.09 % |
0 % |
0 % |
common.calendar.number_days.30d |
0.11 $ |
0 $ |
0 $ |
-9.09 % |
0 % |
0 % |
common.calendar.number_days.90d |
0.15 $ |
0.1 $ |
0.15 $ |
-33.33 % |
0 % |
0 % |
common.calendar.number_days.180d |
0.2 $ |
0.03 $ |
0.42 $ |
-50 % |
0 % |
0 % |
common.calendar.number_days.1y |
0.5 $ |
0.03 $ |
0.55 $ |
-80 % |
0 % |
0 % |
common.calendar.number_days.3y |
0.4 $ |
0.03 $ |
0.99 $ |
-75 % |
0 % |
0 % |
common.calendar.number_days.5y |
0.14 $ |
0.03 $ |
1.44 $ |
-28.57 % |
0 % |
0 % |
common.calendar.number_days.10y |
0.03 $ |
0.03 $ |
1.44 $ |
+366.67 % |
0 % |
0 % |
common.calendar.number_days.ytd |
0.43 $ |
0.03 $ |
0.44 $ |
-76.74 % |
0 % |
0 % |
Entreprises similaires
P/E & P/BVEV/Ebitda & Debt/Ebitda
Gestion d'entreprise
Superviseur |
Titre d'emploi |
Paiement |
Année de naissance |
Mr. James Henry Barder |
CEO & Executive Director |
503.84k |
1959 (66 années) |
Ms. Angela Hildreth |
COO, Finance Director, Company Secretary & Executive Director |
394.36k |
1980 (45 années) |
Mr. Kenneth William James |
Head of R&D & Executive Director |
361.11k |
1952 (73 année) |
Dr. William Duncan Potter |
Chief Scientific Officer & Adviser to the Board |
N/A |
1948 (77 années) |
Graham Smith |
Head of Alliance Partnerships & Supply |
N/A |
|
Kevin Langridge |
Head of Quality |
N/A |
|
Informations sur l'entreprise
À propos de l'entreprise Futura Medical plc
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.